Catechin

Catechin at a Glance

(+)-Catechin is the simplest flavan-3-ol — a saturated, non-planar molecule quite unlike the flat flavones, and one of the monomer units from which condensed tannins are built.

Its name is the main source of confusion about it. “Catechins” as a group covers green tea’s EGCG and cocoa’s epicatechin, and the cardiovascular and metabolic data attributed to “catechin” are almost entirely from those mixtures, in which (+)-catechin itself is a minor passenger.

The one place the isolated molecule has a real history is cianidanol, a former hepatitis drug — which is also where its most serious safety findings come from.

What It's Used For

Catechin — specifically (+)-catechin, the flavan-3-ol monomer — is one of the most studied “dietary antioxidants,” but its evidence base is a masterclass in the isolate-vs-mixture trap. Almost none of the human “catechin” literature tests this molecule. The cardiovascular and metabolic data come from green-tea catechins (a gallated mixture dominated by EGCG) or cocoa flavanols (dominated by the epimer (−)-epicatechin), and much of a plant’s flavan-3-ol content is locked into proanthocyanidins (catechin/epicatechin polymers) — a different chemical class. The one place the evidence is genuinely about isolated (+)-catechin is the withdrawn hepatitis drug cianidanol — and that story is a safety failure, not an efficacy win. Read every benefit below with the question: was the tested agent actually (+)-catechin? Almost always, no.

Evidence by IndicationStrength of support · Beta

Support is an experimental score I’m building — a composite weighted by study type (human > animal > in vitro > review) and study volume, tempered for isolate-vs-mixture match and bioavailability. It’s a beta: a fast way to rank strength of evidence at a glance, not a validated metric. These scores are for isolated (+)-catechin — deliberately capped wherever the evidence rests on a mixture. Each application links to its write-up.

01Cardiovascular & endothelial functionShaky35%Real for cocoa/epicatechin & tea mixtures — but (+)-catechin is the minor passenger, never tested alone ^{1,2,4Reference 1Ried K et al. · 2017Systematic reviewEffect of cocoa on blood pressureView study →Reference 2Sun Y et al. · 2019Meta-analysisDose-response relationship between cocoa flavanols and human endothelial function — a systematic review and meta-analysis of randomised trialsView study →Reference 4Crowe-White KM et al. · 2022Flavan-3-ols and cardiometabolic health — first ever dietary bioactive guidelineView study →}

02Hepatitis (the cianidanol story)Shaky30%The one genuine isolated-(+)-catechin program — weak, inconsistent, and withdrawn for harm ^{5,6Reference 5Schomerus H et al. · 1984RCTSchomerus H, Wiedmann KH, Dölle W, et al. (1984). (+)-Cyanidanol-3 in the treatment of acute viral hepatitis — a randomised controlled trial. Hepatology, 4(2), 331–335. https://pubmed.ncbi.nlm.nih.gov/6368355/View study →Reference 6Suzuki H et al. · 1986RCTCianidanol therapy for HBe-antigen-positive chronic hepatitis — a multicentre, double-blind studyView study →}

03Metabolic — weight, lipids & glucoseShaky25%EGCG-dominated green-tea-extract mixtures; (+)-catechin not the active ^{8,10Reference 8Nagao T et al. · 2007A green tea extract high in catechins reduces body fat and cardiovascular risks in humansView study →Reference 10Xu R et al. · 2020Meta-analysisEffect of green tea consumption on blood lipids — a systematic review and meta-analysis of randomised controlled trialsView study →}

04AntibacterialShaky10%A negative result: inactive where its Pelargonium co-constituents were active ^{27Reference 27Kayser O · 1997In vitroAntibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme — in vitroView study →}

Mechanisms

Pharmacokinetics

(+)-Catechin is absorbed as a monomer in the small intestine (largely passive diffusion), but the fraction reaching the blood intact is small and essentially none circulates as free aglycone — it is rapidly conjugated (glucuronidation, sulfation, 3′-O-methylation) in the enterocyte and liver ^{13Reference 13Di Pede G et al. · 2023Systematic reviewRevisiting the bioavailability of flavan-3-ols in humans — a systematic review and comprehensive data analysisView study →}. In the cleanest human study, pure (+)-catechin from reconstituted red wine gave a plasma peak of only ~77 nmol/L at ~1.4 h, already ~20% methylated and under 2% unconjugated within an hour ^{12Reference 12Bell JR et al. · 2000Bell JR, Donovan JL, Wong R, et al. (2000). (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. The American Journal of Clinical Nutrition, 71(1), 103–108. https://pubmed.ncbi.nlm.nih.gov/10617953/View study →}. These are nanomolar, transient exposures with a short half-life — the same low-plasma / rapid-conjugation pattern the broader flavan-3-ol literature reports ^{14Reference 14Manach C et al. · 2005ReviewBioavailability and bioefficacy of polyphenols in humansView study →}.

Two distinctions are load-bearing. Stereochemistry: (+)-catechin and (−)-epicatechin absorb similarly as monomers but are distinct molecules with distinct metabolite profiles, and neither is the galloylated EGCG (absorbed even more poorly) ^{15Reference 15Natsume M et al. · 2003AnimalStructures of (−)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (−)-epicatechin — differences between human and ratView study →}. Polymerization: monomers are taken up, but the proanthocyanidins are essentially not absorbed intact. The majority of any flavan-3-ol dose (~70%+) reaches the colon, where microbiota cleave the C-ring to phenyl-γ-valerolactones and phenolic acids that dominate the circulating metabolite pool and vary widely between people; mean flavan-3-ol bioavailability across human studies is only ~31% ^{13Reference 13Di Pede G et al. · 2023Systematic reviewRevisiting the bioavailability of flavan-3-ols in humans — a systematic review and comprehensive data analysisView study →}. In practical terms, oral (+)-catechin is modestly absorbed, heavily conjugated, poorly retained, and for a large fraction of any dose effectively a pro-drug for microbiome-generated valerolactones ^{13Reference 13Di Pede G et al. · 2023Systematic reviewRevisiting the bioavailability of flavan-3-ols in humans — a systematic review and comprehensive data analysisView study →}.

Clinical trials

Isolated (+)-catechin has no active modern clinical program — its only dedicated human trials were the abandoned cianidanol hepatitis studies. The large “catechin” trial literature belongs to green-tea catechin and cocoa-flavanol mixtures.

Isolated (+)-catechin	Green-tea catechins	Cocoa flavanols	Proanthocyanidins
Cianidanol (hepatitis, withdrawn)	Many RCTs (EGCG-led)	Many RCTs (epicatechin-led)	Separate class

Last checked: July 2026.

Isolate vs. Plant Studies

For catechin the isolate-vs-whole problem is unusually stark, because “catechin” names four different things. (+)-catechin (the monomer described here) must be kept separate from (−)-epicatechin (its epimer, the main cocoa-flavanol active), from EGCG and the gallated tea catechins (the main green-tea actives), and from proanthocyanidins (the polymers most of a plant’s flavan-3-ols are locked into) ^{21Reference 21Aron PM · 2008Flavan-3-ols — nature, occurrence and biological activityView study →}. The consequence: the cardiovascular evidence is epicatechin/cocoa, the metabolic evidence is EGCG/green tea, and the polymer evidence is a different class — so a “catechin is heart-healthy” claim is an extrapolation from molecules that are not (+)-catechin. Within this database, (+)-catechin turns up as a co-occurring monomer or an antioxidant/standardization marker (in cacao, pine, jatoba, hibiscus and others), almost always alongside epicatechin and usually without a (+)-catechin-specific assay — indeed several repo “catechin” mentions are really about epicatechin, EGCG, or condensed tannins. The one thing genuinely demonstrated for isolated (+)-catechin in humans is a harm (hemolysis, below), not a benefit. The pattern extends past humans: in the one plant screen that put (+)-catechin beside its own co-constituents under identical conditions, the coumarins and gallic acid derivatives of Pelargonium sidoides root were antibacterial and (+)-catechin was not ^{27Reference 27Kayser O · 1997In vitroAntibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme — in vitroView study →} — a reminder that being present in an active extract is not evidence of being the active.

Prevalence in Nature

(+)-Catechin is a widespread flavan-3-ol, found across the plant kingdom in cocoa, tea, pome and stone fruit (apples, peaches, apricots, cherries), grapes and red wine, berries, fava beans and Acacia catechu (the source of catechu/cutch) ^{21,24,25Reference 21Aron PM · 2008Flavan-3-ols — nature, occurrence and biological activityView study →Reference 24Arts IC et al. · 2000Catechin contents of foods commonly consumed in The NetherlandsView study →Reference 25Arts IC et al. · 2000Catechin contents of foods commonly consumed in The NetherlandsView study →}. It occurs in leaves, fruit skins and flesh, seeds and seed coats, almost always co-occurring with (−)-epicatechin, and in most plants the bulk of the flavan-3-ol mass is polymerized into proanthocyanidins — free monomeric (+)-catechin is the minor, soluble fraction. Among common foods the discrete monomer runs roughly 1–20 mg/100 g, with peaches and fava beans among the richest whole foods; red wine carries ~7 mg/100 mL (highly variable, 0–39, by variety and vinification), and — importantly — tea is not a headline (+)-catechin food despite being a headline “catechin” food, because its flavan-3-ols are overwhelmingly the gallated catechins (EGCG > ECG/EGC) ^{24,25Reference 24Arts IC et al. · 2000Catechin contents of foods commonly consumed in The NetherlandsView study →Reference 25Arts IC et al. · 2000Catechin contents of foods commonly consumed in The NetherlandsView study →}. Cocoa is genuinely flavanol-rich but epicatechin- and procyanidin-dominated, so measured dark chocolate is used as the honest cocoa-family anchor on the chart.

Biosynthetically, (+)-catechin is an end-branch of the flavonoid pathway: naringenin → dihydroflavonols → leucoanthocyanidins, from which leucoanthocyanidin reductase (LAR) makes (+)-catechin (2,3-trans) ^{22Reference 22Tanner GJ et al. · 2003Proanthocyanidin biosynthesis in plants — purification of legume leucoanthocyanidin reductase (LAR → (+)-catechin)View study →}. A parallel route runs leucoanthocyanidin → anthocyanidin → (via anthocyanidin reductase, ANR / the BANYULS gene) (−)-epicatechin (2,3-cis) ^{23Reference 23Xie DY et al. · 2003Role of anthocyanidin reductase, encoded by BANYULS, in plant flavonoid biosynthesis (ANR → (−)-epicatechin)View study →}. Both monomers are then the building blocks of the proanthocyanidins. There is essentially no non-plant dietary source — animals do not make it, and gut microbiota degrade rather than synthesize it.

Discovery & Synthesis

“Catechin” is named for catechu (also cutch or khair) — the dark, astringent extract made by boiling and evaporating the heartwood of Acacia catechu (now Senegalia catechu) and related sources, long used as a tannin, dye and astringent — from which the compound was first obtained. Catechin in turn lent its name to the catechol functional group (1,2-dihydroxybenzene). On dating: “catechu” enters English in the seventeenth century and lexicographic sources place the first use of “catechin” in the mid-1800s (attested 1853), consistent with a mid-nineteenth-century isolation from catechu — but no single first-isolator or exact year can be firmly confirmed, so treat it as approximate.

Structurally (+)-catechin is a flavan-3-ol — a flavan bearing a 3-hydroxyl (3,3′,4′,5,7-pentahydroxyflavan) — and, unusually among flavonoids, it carries no 4-oxo (ketone) and no 2,3-double bond, so its C-ring is saturated and non-planar rather than the flat, conjugated system of flavones and flavonols. With two stereocenters (C-2, C-3) it exists as four diastereomers: “catechin” is the 2,3-trans pair and “epicatechin” the 2,3-cis pair, with (+)-catechin and (−)-epicatechin the two common natural forms. Commercially it is obtained by extraction from plant material — catechu/gambier (Acacia/Uncaria), tea and other catechin-rich botanicals — followed by chromatographic purification; enantioselective total syntheses exist for research but are not the bulk route.

Patents: not yet researched (future patent-loop pass).

Toxicity & Safety

At dietary levels — tea, cocoa, apples, grapes, beans — (+)-catechin has very low toxicity and an unremarkable safety record. The concern is the concentrated, chronically dosed isolate, and here catechin carries a genuinely important, on-target cautionary tale. Marketed as the drug cianidanol (“Catergen”) in gram-scale daily doses for hepatitis, isolated (+)-catechin was withdrawn after causing acute immune (drug-induced) hemolytic anemia — with fever, thrombocytopenia and, when hemolysis was severe and intravascular, secondary acute renal failure that could be life-threatening ^{16Reference 16Rotoli B et al. · 1985Immune-mediated acute intravascular haemolysis caused by cianidanol (Catergen)View study →}. The mechanism was worked out: cianidanol and its metabolites bind tightly to red cells, provoking both drug-dependent antibodies and, in some patients, true red-cell autoantibodies ^{17,18Reference 17Salama A · 1987Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto- and/or drug-dependent antibodies against these cellsView study →Reference 18Pausch V · 1983Immunohaematologic examination of correlations between cyanidanol-3 therapy and haemolytic anaemiaView study →}. The reaction was episodic and resolved on stopping the drug, and it does not imply that dietary catechin causes hemolysis — but it is a documented, mechanistically understood hazard of the isolated compound at pharmacological dose ^{16,17,19Reference 16Rotoli B et al. · 1985Immune-mediated acute intravascular haemolysis caused by cianidanol (Catergen)View study →Reference 17Salama A · 1987Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto- and/or drug-dependent antibodies against these cellsView study →Reference 19Pár A et al. · 1983Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitisView study →}.

The best-established interaction is with iron: like other polyphenols, flavan-3-ols chelate and reduce absorption of non-heme (dietary/supplemental) iron when taken with a meal, relevant for iron-deficient people, menstruating women and pregnancy ^{20Reference 20Hurrell RF et al. · 1999Inhibition of non-haem iron absorption in man by polyphenolic-containing beveragesView study →}. CYP-enzyme and transporter effects exist in vitro but are not established as clinically meaningful for (+)-catechin at the low plasma levels diet produces, and should be read as plausibility signals, not confirmed interactions.

Dosage

There is no isolated-(+)-catechin dose in current use. The only isolated-monomer dosing precedent is the withdrawn drug cianidanol (~1.5–3 g/day for hepatitis), abandoned for the hemolysis risk above ^{5,19Reference 5Schomerus H et al. · 1984RCTSchomerus H, Wiedmann KH, Dölle W, et al. (1984). (+)-Cyanidanol-3 in the treatment of acute viral hepatitis — a randomised controlled trial. Hepatology, 4(2), 331–335. https://pubmed.ncbi.nlm.nih.gov/6368355/View study →Reference 19Pár A et al. · 1983Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitisView study →}. Where a target is quoted, it is for flavan-3-ols as a dietary class — roughly 400–600 mg/day from foods in the dietary-bioactive guideline — which is a food-pattern recommendation (tea, cocoa, apples, berries), not a dose of the (+)-catechin monomer ^{4Reference 4Crowe-White KM et al. · 2022Flavan-3-ols and cardiometabolic health — first ever dietary bioactive guidelineView study →}.

These are descriptive, not a recommendation — no dose of isolated (+)-catechin is supported for any benefit, and the gram-scale isolate has a documented hemolysis risk. Ordinary dietary intake from foods is the sensible frame.

References

1. Ried K, Fakler P, Stocks NP. (2017). Effect of cocoa on blood pressure. Cochrane Database of Systematic Reviews, 4, CD008893. https://pubmed.ncbi.nlm.nih.gov/28439881/
2. Sun Y, Zimmermann D, De Castro CA, Actis-Goretta L. (2019). Dose-response relationship between cocoa flavanols and human endothelial function — a systematic review and meta-analysis of randomised trials. Food & Function, 10(10), 6322–6330. https://pubmed.ncbi.nlm.nih.gov/31524216/
3. Dower JI, Geleijnse JM, Gijsbers L, et al. (2015). Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre)hypertensive adults (tests (−)-epicatechin, the epimer). The Journal of Nutrition, 145(7), 1459–1463. https://pubmed.ncbi.nlm.nih.gov/25972527/
4. Crowe-White KM, Evans LW, Kuhnle GGC, et al. (2022). Flavan-3-ols and cardiometabolic health — first ever dietary bioactive guideline. Advances in Nutrition, 13(6), 2070–2083. https://pubmed.ncbi.nlm.nih.gov/36190328/
5. Schomerus H, Wiedmann KH, Dölle W, et al. (1984). (+)-Cyanidanol-3 in the treatment of acute viral hepatitis — a randomised controlled trial. Hepatology, 4(2), 331–335. https://pubmed.ncbi.nlm.nih.gov/6368355/
6. Suzuki H, et al. (1986). Cianidanol therapy for HBe-antigen-positive chronic hepatitis — a multicentre, double-blind study. Liver, 6(1), 35–44. https://pubmed.ncbi.nlm.nih.gov/3520204/
7. Piazza M, Guadagnino V, Picciotto L, et al. (1983). Effect of (+)-cyanidanol-3 in acute HAV, HBV, and non-A, non-B viral hepatitis. Hepatology, 3(1), 45–49. https://pubmed.ncbi.nlm.nih.gov/6401668/
8. Nagao T, Hase T, Tokimitsu I. (2007). A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity, 15(6), 1473–1483. https://pubmed.ncbi.nlm.nih.gov/17557985/
9. Phung OJ, Baker WL, Matthews LJ, et al. (2010). Effect of green tea catechins with or without caffeine on anthropometric measures — a systematic review and meta-analysis. The American Journal of Clinical Nutrition, 91(1), 73–81. https://pubmed.ncbi.nlm.nih.gov/19906797/
10. Xu R, Yang K, Li S, et al. (2020). Effect of green tea consumption on blood lipids — a systematic review and meta-analysis of randomised controlled trials. Nutrition Journal, 19(1), 48. https://pubmed.ncbi.nlm.nih.gov/32434539/
11. Zheng XX, Xu YL, Li SH, et al. (2013). Effects of green tea catechins with or without caffeine on glycaemic control in adults — a meta-analysis of randomised controlled trials. The American Journal of Clinical Nutrition, 97(4), 750–762. https://pubmed.ncbi.nlm.nih.gov/23426037/
12. Bell JR, Donovan JL, Wong R, et al. (2000). (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. The American Journal of Clinical Nutrition, 71(1), 103–108. https://pubmed.ncbi.nlm.nih.gov/10617953/
13. Di Pede G, Mena P, Bresciani L, et al. (2023). Revisiting the bioavailability of flavan-3-ols in humans — a systematic review and comprehensive data analysis. Molecular Aspects of Medicine, 89, 101146. https://pubmed.ncbi.nlm.nih.gov/36207170/
14. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. (2005). Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition, 81(1 Suppl), 230S–242S. https://pubmed.ncbi.nlm.nih.gov/15640486/
15. Natsume M, Osakabe N, Oyama M, et al. (2003). Structures of (−)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (−)-epicatechin — differences between human and rat. Free Radical Biology & Medicine, 34(7), 840–849. https://pubmed.ncbi.nlm.nih.gov/12654472/
16. Rotoli B, Giglio F, Bile M, Formisano S. (1985). Immune-mediated acute intravascular haemolysis caused by cianidanol (Catergen). Haematologica, 70(6), 495–499. https://pubmed.ncbi.nlm.nih.gov/3938427/
17. Salama A, Mueller-Eckhardt C. (1987). Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto- and/or drug-dependent antibodies against these cells. British Journal of Haematology, 66(2), 263–266. https://pubmed.ncbi.nlm.nih.gov/3606962/
18. Pausch V, Göbel J. (1983). Immunohaematologic examination of correlations between cyanidanol-3 therapy and haemolytic anaemia. Wiener Medizinische Wochenschrift, 133(15–16), 415–419. https://pubmed.ncbi.nlm.nih.gov/6419470/
19. Pár A, Paál M, Kádas I, et al. (1983). Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. Acta Medica Hungarica, 40(2–3), 173–182. https://pubmed.ncbi.nlm.nih.gov/6664741/
20. Hurrell RF, Reddy M, Cook JD. (1999). Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages. The British Journal of Nutrition, 81(4), 289–295. https://pubmed.ncbi.nlm.nih.gov/10999016/
21. Aron PM, Kennedy JA. (2008). Flavan-3-ols — nature, occurrence and biological activity. Molecular Nutrition & Food Research, 52(1), 79–104. https://pubmed.ncbi.nlm.nih.gov/18081206/
22. Tanner GJ, Francki KT, Abrahams S, et al. (2003). Proanthocyanidin biosynthesis in plants — purification of legume leucoanthocyanidin reductase (LAR → (+)-catechin). The Journal of Biological Chemistry, 278(34), 31647–31656. https://pubmed.ncbi.nlm.nih.gov/12788945/
23. Xie DY, Sharma SB, Paiva NL, Ferreira D, Dixon RA. (2003). Role of anthocyanidin reductase, encoded by BANYULS, in plant flavonoid biosynthesis (ANR → (−)-epicatechin). Science, 299(5605), 396–399. https://pubmed.ncbi.nlm.nih.gov/12532018/
24. Arts IC, van de Putte B, Hollman PC. (2000). Catechin contents of foods commonly consumed in The Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. Journal of Agricultural and Food Chemistry, 48(5), 1746–1751. https://pubmed.ncbi.nlm.nih.gov/10820089/
25. Arts IC, van de Putte B, Hollman PC. (2000). Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. Journal of Agricultural and Food Chemistry, 48(5), 1752–1757. https://pubmed.ncbi.nlm.nih.gov/10820090/
26. U.S. Department of Agriculture, Agricultural Research Service. USDA Database for the Flavonoid Content of Selected Foods, Release 2.1 (2007) — (+)-catechin, mg/100 g. https://www.ars.usda.gov/ARSUserFiles/80400525/data/flav/flav02-1.pdf
27. Kayser O, Kolodziej H (1997). Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme — in vitro. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/9434601/

View all 27 references▾